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the intensive care unit with a high inci-
dence of delayed sternal closure. Open
sternums do translate into a high risk
of infection in tropical countries2 and
may adversely affect the outcome.
Also with a single-stage strategy, ex-
tracorporeal membrane oxygenation
support may not always be available
if there is difficulty weaning these pa-
tients from CPB, particularly after an
extensive 2-stage procedure in a neo-
nate. Under these circumstances, if
the anatomy of the CoA is suitable
for repair and there is no need for
arch repair, a 2-stage approach can
often be justified, particularly in the
neonatal age group in whom the risk
of CPB and total circulatory arrest re-
lated complications is higher. These
patients can have the VSD closure in
a safe manner at a later stage, which
is also technically simpler in an older
patient.
In patients beyond the neonatal pe-
riod with uncomplicated CoA, we pre-
fer the single-stage approach described
by Kanter and colleagues,3 in which
the CoA is first repaired via a postero-
lateral thoracotomy, the patient is
turned supine, and the VSD is closed
using standard CPB. The advantages
of this approach are its simplicity, bet-
ter CoA management (debatable), less
CPB times, and avoidance of circula-
tory arrest. However, this strategy is
not applicable to patients with arch
hypoplasia and has the disadvantage
of 2 incisions.
In most of the public hospitals in In-
dia and other developing countries, an
initial repair of the CoA costs approx-
imately $500 and a subsequent second
stage can be accomplished at less than
$1500, but if we were to adopt a 1-
stage approach, we may incur a sub-
stantial increase in costs because of
a higher morbidity and longer inten-
sive care unit stay. Despite the claimed
advantages of a single-stage approach,
we continue to advocate the 2-stage
approach in developing countries, par-
ticularly in those centers where ‘‘profi-
ciency’’ has not been achieved in
managing these critically ill small neo-
nates. The authors are to be congratu-
lated on successfully achieving this.
Sachin Talwar, MCh
Shiv Kumar Choudhary, MCh
Balram Airan, MCh
Cardiothoracic Center
All India Institute of Medical Sciences
New Delhi, India
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Reply to the Editor:
As Talwar and colleagues state in
their Letter to the Editor, we acknowl-
edged the obvious and unavoidable era
bias in our article. The 3 patients who
underwent repair of coarctation (CoA)
of the aorta alone, using a median ster-
notomy incision with cardiopulmo-
nary bypass, had significant proximal
aortic arch hypoplasia that precluded
satisfactory repair through a left pos-
terolateral thoracotomy incision. In
the era during which those patients
presented, we were not performing
single-stage repair of CoA with ven-
tricular septal defect (VSD).
We agree that the socioeconomic
context in which the patient with CoA-
VSD presents should be considered
when choosing the surgical strategy,
namely, single- versus 2-stage repair.
Similarly, institutional resources and
surgeon-specific variables should also
be factored into this decision. We have
documented, in our own institutional
experience, that the increased need for
delayed sternal closure has now been
neutralized1 and that the risk of media-
stinitis with delayed sternal closure,
when used, is minimal,2 but the same
may not be true in other centers.
Nonetheless, the advantages of
single-stage repair that we have clearly
documented, such as earlier age at com-
plete repair, as well as the hypothetical
advantages that we have postulated,
such as better neurodevelopmental out-
comes related to earlier complete repair,
may, in the end, transcend the economic
advantages of 2-stage repair. Therefore,
the single-stage repair of CoA-VSD
could, in the future, become a goal
worth pursuing in all centers regardless
of socioeconomic barriers. With further
research on neurodevelopmental out-
comes, the advantages of this technique
may become important enough to serve
as a stimulus for the development of re-
sources to accommodate its successful
and improved implementation.
Henry L. Walters, III, MD
Department of Cardiovascular Surgery
Children’s Hospital of Michigan
Detroit Medical Center
Wayne State University School of
Medicine
Detroit, Mich
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Letters to the Editor
The Journal of Thoracic and Cardiovascular SurgerSOLID AND GASEOUS
CEREBRAL
MICROEMBOLIZATION AFTER
BIOLOGIC AND MECHANICAL
AORTIC VALVE
REPLACEMENT:
INVESTIGATION WITH
MULTIRANGE AND
MULTIFREQUENCY
TRANSCRANIAL DOPPLER
ULTRASOUND
To the Editor:
We read with interest the recent arti-
cle by Guerrieri Wolf and colleagues1y c Volume 136, Number 5 1391
Reply to the Editor:
We thank Nowell and Jahangiri for
their interest in our recent article1 us-
ing a novel transcranial Doppler sys-
tem (Embo-Dop; DWL Elektronische
Systeme GmbH, Singen, Germany)
to investigate the number and nature
of cerebral microemboli in recipients
of biological and mechanical aortic
valve prostheses. The 2 important is-
sues highlighted by the authors in their
Letter to the Editor were, in fact, both
discussed specifically in our article.
The first issue is the potentially low
sensitivity and specificity of the
Embo-Dop system as suggested in
the clinical validation study byMarkus
and Punter.2 With specific regard to
that study, we wrote in the discussion
section of our article: ‘‘More recently,
Markus and Punter, while confirming
the superior discrimination achievable
with this new Embo-Dop transcranial
Doppler system compared with
conventional transcranial Doppler
ultrasound, reported it to have a sensi-
tivity of only 50% but a specificity of
96% for detecting solid microemboli
in vivo. If confirmed, that finding
will only serve to emphasize the al-
ready significantly greater solid micro-
embolic load detected with mechanical
rather than biological prostheses.’’ In
other words, because the sensitivity
of the Embo-Dop system is much
lower than its specificity in detecting
solid microemboli, this will result in
an underestimation of the solid cere-
bral microembolic load.
The second issue raised by Nowell
and Jahangiri is that the reduction of
solid microemboli over time in the bi-
ological prosthesis recipients, but not
in the mechanical prosthesis recipi-
ents, could be explained by the use of
aspirin in the first group. Again, we
discussed that issue in our article stat-
ing, ‘‘Although biological recipients
were all receiving aspirin, mechanical
recipients received warfarin without
any antiplatelet agents. This could ex-
plain the reduction in the proportion of
particulate microemboli over time in
the biological valve group but not in
the mechanical group.’’ We subse-
quently suggested, ‘‘However, the re-
sults could also be affected by the
use of aspirin in the biologic valve
group, which would explain the reduc-
tion of microemboli detected over time
in group B (biological) but not in
group M (mechanical). Indeed, using
aspirin instead of warfarin after a
biological aortic valve implantation
is the current practice among the
Letters to the Editordescribing their experience of a trans-
cranial Doppler system (Embo-Dop;
DWL Elektronische Systeme GmbH,
Singen, Germany) to discriminate be-
tween gaseous and particulate emboli
after aortic valve replacement. The
main finding of their study was that
solid microemboli occurred more fre-
quently after mechanical aortic valve
replacement compared with biological
valve replacement at 3 months after
surgery. The inability to distinguish
the difference between solid and gas-
eous microemboli has limited the use
of standard transcranial Doppler
when both coexist, for example, dur-
ing open carotid endarterectomy.
As the authors state, this particular
Doppler technique was first assessed
by Brucher and Russell2 in a 2-part
study comprising both in vitro and
in vivo models. The in vivo part
used 45 patients with carotid artery
stenosis (39 symptomatic), producing
a relatively low number of 32 em-
bolic signals, of which 30 were clas-
sified as solid.
The assumption in validation studies
is that all patients with carotid artery ste-
nosis produce only solid emboli. One
arm of a clinical validation study per-
formed by Markus and Punter3 used
a cohort of patients with symptomatic
carotid artery stenosis to generate 145
presumed solid embolic signals. Of
these145signals, theEmbo-Dopsystem
classified 72 as gaseous emboli. This
gavea sensitivity of 50.3% and specific-
ity of 96.5% for detecting solid embolic
signals. Markus and Punter concluded
that although the Embo-Dop system
allowed better discrimination than
simple intensity threshold alone, it
was not accurate enough for clinical
or research studies. Unless the specific-
ity is approximately 100%, a significant
number will be classified wrongly as
potentially significant solid emboli.
We believe that Embo-Dop has to be
used with caution in distinguishing gas-
eous from solid emboli.
The authors comment on no antipla-
telet therapy after mechanical versus
biological valve replacement. Our1392 The Journal of Thoracic angroup conducted a UK survey of con-
sultant practice and literature review of
this subject.4 We concluded that the
incidence of thromboembolism after
aortic bioprosthesis is highest in the
first 3 months but then diminishes.
Whether this is related to endotheli-
alization of prosthetic material or
specifically to antiplatelet therapy is
unknown. Therefore, their observation
that the proportion of particulate em-
boli at 3 months was in the biological
valve replacement cohort receiving as-
pirin but not in the mechanical group
receiving only warfarin could indeed
be explained by the antiplatelet func-
tion of aspirin.
Justin Nowell, MRCS
Marjan Jahangiri, FRCS (CTh)
St George’s Hospital
London, United Kingdom
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